HomeTagsBioNTech

BioNTech

Biotechnology

Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster for Individuals 12 Years of Age and Older

Business Wire - January 4, 2022

Pfizer Inc. (NYSE: PFE) and BioNTech SE announced that the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) of...

spot_img

Hot Topics

RTX’s Collins Aerospace announces avionics modernization program for King Air and Hawker aircraft

Aptar and Nadara Collaborate to Drive Renewable Energy Generation in Europe

KalVista Appoints Jeb Ledell as Chief Operating Officer